- argenx SE at Barclays Global Healthcare Conference TranscriptMar 12, 2024
- Q4 2023 argenx SE Earnings Call TranscriptFeb 29, 2024€365.8 (-2.64%)Earnings
- argenx SE at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- argenx SE Reports Topline Results from ADDRESS Study of Efgartigimod SC in Pemphigus TranscriptDec 20, 2023
- argenx SE Investor Call TranscriptNov 28, 2023
- Q3 2023 argenx SE Earnings Call TranscriptOct 31, 2023Earnings
- argenx SE at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- argenx SE at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 argenx SE Earnings Call TranscriptJul 27, 2023€464.6 (-2.33%)Earnings
- argenx SE To Discuss the Adhere Results TranscriptJul 17, 2023
- argenx SE To Discuss Drug Administration Approval of VYVGART TranscriptJun 21, 2023
- argenx SE at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 argenx SE Earnings Call TranscriptMay 04, 2023€353.5 (-0.98%)Earnings
- argenx SE at TD Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 argenx SE Earnings Call TranscriptMar 02, 2023€346.9 (+1.82%)Earnings
- argenx SE Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:00 AM TranscriptJan 09, 2023
- argenx SE at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- argenx SE at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 argenx SE Earnings Call TranscriptOct 27, 2022€370.5 (-4.88%)Earnings
- Q2 2022 argenx SE Earnings Call TranscriptJul 28, 2022€350.2 (-1.85%)Earnings
- argenx SE at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- argenx SE at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 argenx SE Earnings Call TranscriptMay 05, 2022€283.3 (+0.35%)Earnings
- argenx SE Topline Phase 3 Data From ADAPT-SC Study Call TranscriptMar 22, 2022
- argenx SE at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 argenx SE Earnings Call TranscriptMar 03, 2022€260.8 (+0.58%)Earnings
- argenx SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- argenx SE To Discuss FDA Approval Call TranscriptDec 17, 2021
- Q3 2021 argenx SE Earnings Call TranscriptOct 28, 2021€239.5 (+0.29%)Earnings
- argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 argenx SE Earnings Call TranscriptJul 29, 2021€252.7 (+0.68%)Earnings
- argenx SE virtual R&D Day Call TranscriptJul 20, 2021
- argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 argenx SE Earnings Call TranscriptMay 14, 2021€213.6 (-1.70%)Earnings
- argenx SE Presents At Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Full Year 2020 argenx SE Earnings Call TranscriptMar 04, 2021€265.2 (-2.21%)Earnings
- argenx SE - Special Call TranscriptFeb 01, 2021
- argenx SE at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- argenx SE at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 argenx SE Earnings Call TranscriptOct 22, 2020€206.6 (-6.01%)Earnings
- argenx SE at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 17, 2020
- argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Half Year 2020 argenx SE Earnings Call TranscriptJul 30, 2020€199.1 (-8.50%)Earnings
- argenx SE at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- argenx SE Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis - Call TranscriptMay 26, 2020
- Q1 2020 argenx SE Earnings and Business Update Call TranscriptMay 14, 2020
- argenx SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q4 2019 argenx SE Earnings Call TranscriptFeb 27, 2020€137.4 (-5.18%)Earnings
- argenx SE at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- argenx SE at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 argenx SE Earnings Call TranscriptAug 01, 2019€131.9 (+5.27%)Earnings
- argenx SE - Special Call TranscriptMay 22, 2019
- Q4 2018 argenx SE Earnings Call TranscriptFeb 28, 2019€116.88 (+3.51%)Earnings
argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Quickly before we get started, I just need to read a disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley representative.
With that, very pleased to have argenx with me and Tim Van. Tim, I can never say your last name. I'm sorry.
Just call it Tim.
Tim, who's CEO; and Keith Woods, who's the COO.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)